tiprankstipranks
NexgenRx Inc (TSE:NXG)
TSXV:NXG
Canadian Market

NexgenRx (NXG) Income Statement

11 Followers

NexgenRx Income Statement

Last quarter (Q4 2023), NexgenRx's total revenue was C$4.29M, an increase of 24.12% from the same quarter last year. In Q4, NexgenRx's net income was C$460.95K. See NexgenRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 14.68MC$ 13.85MC$ 12.78MC$ 11.84MC$ 11.04MC$ 9.54M
Cost of Revenue
C$ 3.20MC$ 3.03MC$ 2.60MC$ 2.03MC$ 1.38MC$ 1.17M
Gross Profit
C$ 11.48MC$ 10.82MC$ 10.18MC$ 9.81MC$ 9.67MC$ 8.37M
Operating Expense
C$ 11.36MC$ 10.96MC$ 9.90MC$ 7.61MC$ 7.51MC$ 8.27M
Operating Income
C$ 122.88KC$ -143.88KC$ 287.66KC$ 2.20MC$ 2.16MC$ 93.52K
Net Non Operating Interest Income Expense
C$ -161.92KC$ -161.18KC$ -153.19KC$ 189.39KC$ -348.23KC$ -374.40K
Other Income Expense
C$ 11.07KC$ 11.07K----
Pretax Income
C$ -50.10KC$ -316.13KC$ 134.47KC$ 2.01MC$ 1.81MC$ -280.89K
Tax Provision
C$ 15.85KC$ 15.85KC$ 156.87KC$ -2.01MC$ -305.76KC$ -72.95K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -65.95KC$ -331.97KC$ -22.40KC$ 4.02MC$ 2.12MC$ -207.94K
Basic EPS
---C$ 0.06C$ 0.03C$ >-0.01
Diluted EPS
---C$ 0.05C$ 0.03C$ >-0.01
Basic Average Shares
C$ 282.71MC$ 70.53MC$ 70.34MC$ 70.34MC$ 69.92MC$ 69.92M
Diluted Average Shares
C$ 279.28MC$ 70.53MC$ 75.20MC$ 74.84MC$ 74.19MC$ 69.92M
Dividend Per Share
--C$ 0.01---
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 9.82KC$ 24.57K
Total Expenses
C$ 10.74M-C$ 12.49MC$ -9.64MC$ 8.88MC$ 9.45M
Net Income From Continuing And Discontinued Operation
C$ -65.95KC$ -331.97KC$ -22.40KC$ 4.02MC$ 2.12MC$ -207.94K
Normalized Income
C$ -36.45KC$ -232.35KC$ 98.83KC$ 1.87KC$ 2.12MC$ -207.94K
Interest Expense
----C$ 208.55KC$ 264.11K
EBIT
C$ 212.16KC$ -154.95KC$ 287.66KC$ 2.07MC$ 2.02MC$ -16.78K
EBITDA
C$ 1.51MC$ 1.15MC$ 1.69MC$ 3.40MC$ 2.96MC$ 815.97K
Currency in CAD

NexgenRx Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis